Systemic meningococcal infection in children of the Arkhangelsk region: predictors of unfavorable course and outcome during different periods of observation

QR Code

Systemic meningococcal infection in children of the Arkhangelsk region: predictors of unfavorable course and outcome during different periods of observation

Invasive meningococcal infection remains a leading cause of death among infectious diseases in children.Aim. to investigate predictors of death in patients with invasive meningococcal infection during two periods of observation: 1991–2011 and 2012–2022.Materials and methods. A retrospective cohort s...

Full description

Saved in:

Bibliographic Details
Main Authors:	O. V. Samodova, T. A. Gordienko, L. V. Ivanova, E. A. Krieger
Format:	Article
Language:	Russian
Published:	Journal Infectology 2024-09-01
Series:	Журнал инфектологии
Subjects:	systemic meningococcal infection children outcome of the disease medical care
Online Access:	https://journal.niidi.ru/jofin/article/view/1665
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Meningococcal infection in children: factors influencing outcome
by: O. V. Samodova, et al.
Published: (2019-10-01)

Systemic meningococcal disease in children: survival analysis, Arkhangelsk region, Northwest Russia, 1991–2011
by: O. V. Samodova, et al.
Published: (2014-09-01)

Meningococcal infection in children in the period 2012–2021. Main results of a retrospective multicenter study, issues of the day
by: A. A. Vilnits, et al.
Published: (2024-01-01)

Meningococcal Urethritis: an additional Source of Meningococcal Disease?
by: N. N. Kostyukova, et al.
Published: (2020-07-01)

Heart damage during meningococcal infection
by: A. A. Grishaeva, et al.
Published: (2024-12-01)

Unusual course of meningococcal infection with lethal outcome (brief communication)
by: V. A. Zinserling, et al.
Published: (2023-07-01)

The important lessons lurking in the history of meningococcal epidemiology
by: Ray Borrow, et al.
Published: (2024-12-01)

Herpesviruses, as a possible cause complicated course of invasive meningococcal disease (clinical case)
by: N. V. Skripchenko, et al.
Published: (2016-07-01)

Meningococcal Vaccines of New Generations – the First 20 Years of Use
by: N. N. Kostyukova, et al.
Published: (2021-09-01)

Generalized Meningococcal Disease in the Newborn: Clinical Case and Literature Review
by: Irina Ya. Izvekova
Published: (2023-05-01)

Integrative Analysis of Predictors for Unfavorable Course of Parkinson Disease According to Medical Care Assessment: Cohort Retrospective Study
by: S. V. Shtaimets, et al.
Published: (2023-02-01)

EPIDEMIOLOGY AND PREVENTION OF MENINGOCOCCAL DISEASE: A CRITICAL APPRAISAL OF VACCINE POLICIES
by: Marco AP Safadi, et al.
Published: (2012-02-01)

World Experience in the Use Serogroup B Meningococcal Vaccines (literature review)
by: I. S. Koroleva, et al.
Published: (2022-01-01)

Meningococcal Infection in Novosibirsk: Changes in Epidemiology and Prevention Problems
by: I. Ya. Izvekova, et al.
Published: (2021-07-01)

Clinical and epidemiological characteristics of meningococcal infection morbidity in Penza Region for the period 2007-2019
by: V. L. Melnikov, et al.
Published: (2021-10-01)

CLINICAL-EPIDEMIOLOGICAL FEATURES AND OUTCOME OF GENERALIZED FORMS OF MENINGOCOCCAL INFECTION IN CHILDREN
by: G. P. Martynova, et al.
Published: (2017-10-01)

Clinical and epidemiological aspects of generalized meningococcal infections in children and adolescents of Saint-Petersburg
by: Yu. V. Lobzin, et al.
Published: (2016-04-01)

Meningococcal disease. Polysaccharide meningococcal vaccines. The historical aspects and the current state of vaccine development. Report 2
by: M. V. Abramtseva, et al.
Published: (2018-02-01)

Past, present, and future policy considerations regarding meningococcal vaccination in the United States
by: Diana E. Clements, et al.
Published: (2024-12-01)

The socioeconomic burden of meningococcal infection in the Russian Federation
by: Yu. V. Lobzin, et al.
Published: (2024-12-01)

Epidemiological Characteristics of Meningococcal Infection in Moscow
by: M. I. Gritsay, et al.
Published: (2020-05-01)

Clinical-epidemiological features of meningococcal infection in children during sporadic morbidity
by: G. P. Martynova, et al.
Published: (2015-07-01)

The Level of Meningococcal Carriage and Genotyping of N. meningitidis Strains in the Group of Labor Migrants
by: M. A. Koroleva, et al.
Published: (2020-11-01)

Meningococcal Carriage: Epidemiology, Causative Agent, Inducing of Immune Protection
by: N. N. Kostyukova, et al.
Published: (2017-10-01)

Safety and Immunogenicity of Meningococcal Groups A and C Polysaccharide Vaccine in Adults 18–60 years of age
by: V. V. Romanenko, et al.
Published: (2023-11-01)

Primary (isolated) meningococcal pericarditis caused by <i>N. meningitidis</i>: case report
by: O. O. Chernysheva, et al.
Published: (2025-03-01)

Serogroup B Protein Meningococcal Vaccines and the Formation of Immune Protection against Gonorrhea
by: N. N. Kostyukova, et al.
Published: (2024-07-01)

The Safety of 4-valent Meningococcal Conjugate Vaccine in Two Years Old Children: Prospective Cohort Study in Sakhalin Region
by: Oxana V. Solonina, et al.
Published: (2019-09-01)

CLASSIFICATION OF UNFAVORABLE OUTCOMES OF THE PERI-OPERATIVE PERIOD
by: D. V. Sаdchikov, et al.
Published: (2019-01-01)

Cost-effectiveness of meningococcal vaccination of infants in the Russian Federation
by: A. V. Rudakova, et al.
Published: (2021-12-01)

Epidemiology of invasive meningococcal disease in Novosibirsk region during 1992–2015
by: I. Ya. Izvekova, et al.
Published: (2016-11-01)

Economic Burden of Invasive Meningococcal Infection in Children in the Republic of Belarus
by: E. N. Sergienko, et al.
Published: (2024-01-01)

Observational Safety Study of Meningococcal Conjugate Vaccine Against Serogroups A, C, W and Y (Menactra) Used in Routine Healthcare Practice for Persons Aged 2 to 55 Years in Russian Federation
by: I. Ya. Izvekova, et al.
Published: (2019-01-01)

the course of a invasive meningococcal disease in a patient of military age from specific prophylaxis (clinical case)
by: V. V. Sharabkhanov, et al.
Published: (2020-06-01)

Evaluation of the potential economic effects in the increased vaccination against meningococcal infection based on real epidemiological data
by: S. V. Svetlichnaya, et al.
Published: (2023-08-01)

Meningococcal disease. Meningococcal conjugate polysaccharide vaccines and new generation vaccines. Report 3
by: M. V. Abramtseva, et al.
Published: (2018-02-01)

Safety of Combination of a Tetravalent Meningococcal Conjugate Vaccine Against Serogroups A, C, Y, W-135 With Other Vaccine Preparations: a Prospective Study of a Series of Cases Among Healthy Children and Children With Various Health Abnormalities
by: Leyla S. Namazova-Baranova, et al.
Published: (2017-06-01)

Dynamics (2014-2019) of Tetravalent Vaccines Against Meningococcal Infection Serogroups A, C, Y and W-135 Use: Prospective Study of Series of Cases Followed by the Monitoring of the Immunization Safety (Using the Conjugate Vaccine as the Example)
by: Diana V. Sutovskaya, et al.
Published: (2020-04-01)

Antibiotic Sensitivity of <i>Neisseria meningitidis</i> Isolated From Patients with Generalized Forms of Meningococcal Infection and From Healthy Carriers
by: E. A. MARTENS, et al.
Published: (2022-09-01)

Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine (MenACWY-D) in Children 9–23 Months of Age in Russian Federation: Results of Russian Part of International Study in Russia and India
by: O. A. Perminova, et al.
Published: (2020-05-01)